Instrumento Inactivo

Otros idiomas Tonix Pharmaceuticals Holding Corp Nasdaq

Acciones

US8902602015

Precio de cierre Nasdaq Otros sitios de cotización
- ^USD	-

09/07	Tonix Pharmaceuticals fija el precio de su oferta pública en 4 millones de dólares; las acciones se desploman	MT
08/07	Tonix Pharmaceuticals tiene la intención de ofrecer y vender acciones de su capital ordinario	CI

Otros idiomas

Desbloquee todas las noticias: ¡Sea el primero en enterarse y reaccione antes que los mercados!

Inscripción 100% Gratuita

Tonix Pharmaceuticals : Short Investor Presentation July 2024	15/07
Tonix Pharmaceuticals : TNX-102 SL for Fibromyalgia and Long COVID	15/07
Tonix Pharmaceuticals Announces Closing of $4.0 Million Public Offering	10/07
Tonix Pharmaceuticals Prices $4 Million Public Offering; Shares Plunge	09/07
Tonix Pharmaceuticals Reports Final Positive Pre-NDA Meeting with FDA for Tonmya for the Management of Fibromyalgia	09/07
Tonix Pharmaceuticals Announces Pricing of Approximately $4.0 Million Public Offering	09/07
Tonix Pharmaceuticals Holding Corp. announced that it expects to receive $30 million in funding	09/07
Tonix Pharmaceuticals Intends to Offer and Sell Shares of its Common Stock	08/07
Tonix Pharmaceuticals Plans Stock Offering; Shares Fall After-Hours	08/07
Tonix Pharmaceuticals Announces Proposed Public Offering	08/07
Tonix Pharmaceuticals Gets FDA Nod to Proceed With New Drug Application for Tonmya in Fibromyalgia	08/07
Tonix Pharmaceuticals Reports Final Positive Pre-NDA Meeting with FDA for Tonmya™ for the Management of Fibromyalgia	08/07
Tonix Pharmaceuticals Reports Final Positive Pre-NDA Meeting with FDA for Tonmya? for the Management of Fibromyalgia	08/07
Tonix Pharmaceuticals Awarded Up to $34 Million U.S. Department of Defense Contract for Accelerated Development of Broad-Spectrum Antiviral Program	01/07
Tonix Pharmaceuticals Receives Up to $34 Million U.S. Department of Defense Contract for Accelerated Development of Broad-Spectrum Antiviral Program	01/07
Tonix Pharmaceuticals Closes $4 Million Offering	28/06
Tonix Pharmaceuticals Announces Closing of $4.0 Million Public Offering	28/06
Top Midday Decliners	27/06
Wall Street Set to Open Marginally Lower Thursday as Investors Parse Bullish Economic Data	27/06
Tonix Pharmaceuticals Announces Pricing of Approximately $4.0 Million Public Offering	27/06

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Tonix Pharmaceuticals Holding Corp Nasdaq

Acciones

US8902602015

Otros idiomas

Filtros